$3.78
-0.27-6.67%
À la fermeture: -
$3.86
0.082.12%
Après les heures de négociation: 7:40 PM EDT
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Salarius Pharmaceuticals Inc (NASDAQ:SLRX) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 54.16K à 117.00K. Cela représente 12.4% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Salarius Pharmaceuticals Corp (XNAS:SLRX) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 226.15K actions échangées par jour, il faudrait 1 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
117.00K
Intérêt à court terme %
12.4%
Jours de couverture
1
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
SLRX | Salarius Pharmaceuticals, Inc. | 09/30/2025 | 10/09/2025 | 12.40% | 943,871 | 117,000 | 226,153 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 09/15/2025 | 09/24/2025 | 10.64% | 508,926 | 54,157 | 354,651 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 08/29/2025 | 09/10/2025 | 24.33% | 508,926 | 123,799 | 201,331 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 08/15/2025 | 08/26/2025 | — | 508,989 | 1,187,013 | 1,040,195 | 1.14 | |
SLRX | Salarius Pharmaceuticals, Inc. | 07/31/2025 | 08/11/2025 | 37.97% | 2,116,541 | 803,608 | 9,544,098 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 07/15/2025 | 07/24/2025 | 32.06% | 2,116,541 | 678,491 | 239,866 | 2.83 | |
SLRX | Salarius Pharmaceuticals, Inc. | 06/30/2025 | 07/10/2025 | 33.35% | 2,116,541 | 705,803 | 7,020,149 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 06/13/2025 | 06/25/2025 | 1.48% | 2,116,541 | 31,420 | 55,681 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 05/30/2025 | 06/10/2025 | 2.27% | 2,116,541 | 47,988 | 18,357 | 2.61 | |
SLRX | Salarius Pharmaceuticals, Inc. | 05/15/2025 | 05/27/2025 | 2.49% | 2,116,541 | 52,652 | 35,063 | 1.5 | |
SLRX | Salarius Pharmaceuticals, Inc. | 04/30/2025 | 05/09/2025 | 3.98% | 2,116,541 | 84,158 | 46,307 | 1.82 | |
SLRX | Salarius Pharmaceuticals, Inc. | 04/15/2025 | 04/25/2025 | 5.34% | 2,116,541 | 112,934 | 415,960 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 03/31/2025 | 04/09/2025 | 8.05% | 1,717,250 | 138,176 | 654,925 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 03/14/2025 | 03/25/2025 | 2.35% | 1,717,250 | 40,435 | 42,906 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 02/28/2025 | 03/11/2025 | 5.45% | 1,572,822 | 85,721 | 362,710 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 02/14/2025 | 02/26/2025 | 0.66% | 1,572,822 | 10,411 | 74,551 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 01/31/2025 | 02/11/2025 | 1.23% | 1,572,822 | 19,341 | 338,181 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 01/15/2025 | 01/27/2025 | 19.82% | 1,572,822 | 311,722 | 13,592,213 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 12/31/2024 | 01/10/2025 | 2.18% | 1,430,412 | 31,114 | 136,273 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 12/13/2024 | 12/24/2024 | 1.84% | 1,430,412 | 26,336 | 31,848 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 11/29/2024 | 12/10/2024 | 2.54% | 1,430,412 | 36,355 | 29,162 | 1.25 | |
SLRX | Salarius Pharmaceuticals, Inc. | 11/15/2024 | 11/26/2024 | 3.84% | 1,430,412 | 54,982 | 31,099 | 1.77 | |
SLRX | Salarius Pharmaceuticals, Inc. | 10/31/2024 | 11/11/2024 | 4.55% | 1,430,413 | 65,040 | 873,513 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 10/15/2024 | 10/24/2024 | 0.11% | 1,430,413 | 1,528 | 752,486 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 09/30/2024 | 10/09/2024 | 1.05% | 1,430,413 | 15,020 | 74,925 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 09/13/2024 | 09/24/2024 | 0.66% | 1,430,413 | 9,397 | 55,567 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 08/30/2024 | 09/11/2024 | 1.07% | 1,430,413 | 15,326 | 153,594 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 07/31/2024 | 08/09/2024 | 14.72% | 586,310 | 86,315 | 10,529,352 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 07/15/2024 | 07/24/2024 | 10.22% | 586,310 | 59,939 | 249,670 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 06/28/2024 | 07/10/2024 | 3.24% | 586,310 | 18,969 | 94,444 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 06/14/2024 | 06/26/2024 | 5.44% | 586,310 | 31,873 | 67,416 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 05/31/2024 | 06/11/2024 | 0.58% | 4,690,483 | 27,295 | 23,906 | 1.14 | |
SLRX | Salarius Pharmaceuticals, Inc. | 05/15/2024 | 05/24/2024 | 0.71% | 4,690,483 | 33,483 | 35,250 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 04/30/2024 | 05/09/2024 | 1.57% | 4,690,483 | 73,617 | 22,872 | 3.22 | |
SLRX | Salarius Pharmaceuticals, Inc. | 04/15/2024 | 04/24/2024 | 2.46% | 4,690,483 | 115,612 | 50,870 | 2.27 | |
SLRX | Salarius Pharmaceuticals, Inc. | 03/28/2024 | 04/09/2024 | 6.36% | 4,228,135 | 268,900 | 616,904 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 03/15/2024 | 03/26/2024 | 0.37% | 3,852,135 | 14,387 | 25,879 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 02/29/2024 | 03/11/2024 | 0.47% | 3,852,135 | 18,010 | 37,271 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 01/31/2024 | 02/09/2024 | 0.21% | 3,852,135 | 8,255 | 23,401 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 01/12/2024 | 01/24/2024 | 0.16% | 3,852,135 | 6,078 | 38,779 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 12/29/2023 | 01/10/2024 | 0.25% | 3,852,135 | 9,698 | 40,893 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 12/15/2023 | 12/27/2023 | 0.18% | 3,852,135 | 6,968 | 33,453 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 11/30/2023 | 12/11/2023 | 0.65% | 3,852,135 | 24,866 | 36,578 | 1 | |
SLRX | Salarius Pharmaceuticals, Inc. | 11/15/2023 | 11/27/2023 | 1.47% | 3,852,135 | 56,634 | 37,080 | 1.53 | |
SLRX | Salarius Pharmaceuticals, Inc. | 10/31/2023 | 11/09/2023 | 2.06% | 3,555,135 | 73,210 | 41,788 | 1.75 | |
SLRX | Salarius Pharmaceuticals, Inc. | 10/13/2023 | 10/24/2023 | 0.87% | 3,555,135 | 30,909 | 176,375 | 1 |
À la recherche des actions les plus vendues à découvert?